Current and Future Medical Approaches To Combat the Anthrax Threat
- 26 January 2010
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 53 (11), 4305-4331
- https://doi.org/10.1021/jm901024b
Abstract
No abstract availableThis publication has 100 references indexed in Scilit:
- Medical countermeasures to protect humans from anthrax bioterrorismTrends in Microbiology, 2009
- An approach to characterizing single‐subunit mutations in multimeric prepores and pores of anthrax protective antigenProtein Science, 2008
- Towards a human oral vaccine for anthrax: The utility of a Salmonella Typhi Ty21a-based prime-boost immunization strategyVaccine, 2008
- Design and Synthesis of Aryl Ether Inhibitors of the Bacillus Anthracis Enoyl‐ACP ReductaseChemMedChem, 2008
- Novel inhibitors of anthrax edema factorBioorganic & Medicinal Chemistry, 2008
- Selection and evaluation of the immunogenicity of protective antigen mutants as anthrax vaccine candidatesVaccine, 2008
- A high-throughput screening approach to anthrax lethal factor inhibitionBioorganic Chemistry, 2007
- Inhibition of S. aureus α-hemolysin and B. anthracis lethal toxin by β-cyclodextrin derivativesBioorganic & Medicinal Chemistry, 2007
- Multicomponent anthrax toxin display and delivery using bacteriophage T4Vaccine, 2007
- Rabies virus glycoprotein as a carrier for anthrax protective antigenVirology, 2006